Remove 2023 Remove Coronary Artery Disease Remove Heart Failure
article thumbnail

2023 ESH Hypertension Guideline Update: Bringing Us Closer Together Across the Pond

American College of Cardiology

Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.

article thumbnail

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

DAIC

Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

article thumbnail

Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

European Journal of Heart Failure

AHF, acute heart failure; CABG, coronary artery bypass graft; CI, confidence interval; CV, cardiovascular; GDMT, guideline-directed medical therapy; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; OR, odds ratio; PCI, percutaneous coronary intervention.

article thumbnail

A world-class institute dedicated to the treatment of all heart conditions has been inaugurated in Thailand.

Heart 2023 Conference

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.

article thumbnail

From the Member Sections | Tackling the Polypharmacy Pandemic in CV Care

American College of Cardiology

Self-reported adherence to cardiovascular medications in patients who have coronary artery disease is for the combination of aspirin, beta-blocker and a lipid-lowering agent in surveys.7 Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement from the American Heart Association. Circulation.

article thumbnail

The efficacy of traditional Chinese herbal medicine across multiple cardiovascular diseases: an umbrella review of systematic reviews of randomized controlled trials

Journal of Cardiovascular Pharmacology

Traditional Chinese herbal medicine (CHM) has been extensively used in cardiovascular disease in modern clinical practice, alone or in combination with conventional treatment. From inception until August 2023, we systematically searched five public literature databases to conduct the umbrella review.

article thumbnail

FAQs about the Cardiology Recertification Exam

BoardVitals - Cardiovascular

The Cardiology MOC exam will be offered on April 3, 2023, and October 11, 2023. The Cardiology MOC exam covers the following subjects : Arrhythmias 15% Coronary Artery Disease 21.5% What are some things you need to know before you sit for the exam? How much does the exam cost? What does the exam cover?